Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study

OBJECTIVE: To assess the efficacy and safety of modified-release (MR) versus immediate-release (IR) prednisone in newly diagnosed glucocorticoid (GC)-naïve patients with polymyalgia rheumatica (PMR). METHODS: Patients were randomised to double-blind MR prednisone (taken at approximately 22:00) or IR...

Descripción completa

Detalles Bibliográficos
Autores principales: Cutolo, Maurizio, Hopp, Michael, Liebscher, Stefan, Dasgupta, Bhaskar, Buttgereit, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Vasculitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372105/
https://www.ncbi.nlm.nih.gov/pubmed/28405475
http://dx.doi.org/10.1136/rmdopen-2016-000426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372105/
https://www.ncbi.nlm.nih.gov/pubmed/28405475
http://dx.doi.org/10.1136/rmdopen-2016-000426

Ejemplares similares